Dr. Sarah Goldberg is an Associate Professor of Medicine in the section of Medical Oncology at the Yale School of Medicine. She is the Division Chief of Thoracic Oncology and also works as a clinician at the Yale Cancer Center and conducts clinical and translational research on lung cancer. In addition, she completed a Masters in Public Health degree which provided her with a foundation of skills in clinical trial design and biostatistics. The focus of her research is investigating biomarkers and novel treatment strategies in non-small cell lung cancer. Her specific research interests include EGFR mutation positive lung cancer, immunotherapeutics for lung cancer, and brain metastases.
Carcinoma, Non-Small-Cell Lung; Immunotherapy; Lung; Medical Oncology; Thoracic Neoplasms